Related references
Note: Only part of the references are listed.Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors
Anne Hollerbach et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome
Paola Adele Lonati et al.
FRONTIERS IN IMMUNOLOGY (2019)
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies
Mimi Y. Kim et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome
Hui Shi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
The Complement Alternative Pathway and Preeclampsia
Layan Alrahmani et al.
CURRENT HYPERTENSION REPORTS (2018)
The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review
Ricard Cervera et al.
JOURNAL OF AUTOIMMUNITY (2018)
Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis
Savino Sciascia et al.
RHEUMATOLOGY (2018)
Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays
W. Chayoua et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Pregnancy-induced atypical haemolytic uremic syndrome: A new era with eculizumab
Renuka Shanmugalingam et al.
OBSTETRIC MEDICINE (2018)
Germline mutations in the alternative pathway of complement predispose to HELLP syndrome
Arthur J. Vaught et al.
JCI INSIGHT (2018)
Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways
Charithani B. Keragala et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE
Joan T. Merrill et al.
LUPUS SCIENCE & MEDICINE (2018)
Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study
R. Hisada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
The role of platelets in antiphospholipid syndrome
G. Baroni et al.
PLATELETS (2017)
Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting
Aleksandra Antovic et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery
Pier Luigi Meroni et al.
BLOOD (2016)
Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus
Anne E. Tebo et al.
CLINICA CHIMICA ACTA (2016)
Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome
Arthur J. Vaught et al.
EXPERIMENTAL HEMATOLOGY (2016)
Anti-beta-2 glycoprotein I epitope specificity: from experimental models to diagnostic tools
P. L. Meroni
LUPUS (2016)
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
Charis Pericleous et al.
PLOS ONE (2016)
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results
Cecile M. Yelnik et al.
LUPUS SCIENCE & MEDICINE (2016)
Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE
Vinicius Domingues et al.
LUPUS SCIENCE & MEDICINE (2016)
Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study
Stephane Zuily et al.
RHEUMATOLOGY (2015)
An independent validation of the Global Anti-Phospholipid Syndrome Score in a Japanese cohort of patients with autoimmune diseases
K. Oku et al.
LUPUS (2015)
Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study
P. Mustonen et al.
LUPUS (2014)
Thrombotic Risk Assessment in Systemic Lupus Erythematosus: Validation of the Global Antiphospholipid Syndrome Score in a Prospective Cohort
Savino Sciascia et al.
ARTHRITIS CARE & RESEARCH (2014)
Relation of Platelet C4d with All-Cause Mortality and Ischemic Stroke in Patients with Systemic Lupus Erythematosus
Amy H. Kao et al.
TRANSLATIONAL STROKE RESEARCH (2014)
Utility of Antiphosphatidylserine/Prothrombin and IgA Antiphospholipid Assays in Systemic Lupus Erythematosus
Ehtisham Akhter et al.
JOURNAL OF RHEUMATOLOGY (2013)
Eculizumab for the treatment of preeclampsia/HELLP syndrome
R. M. Burwick et al.
PLACENTA (2013)
GAPSS: the Global Anti-Phospholipid Syndrome Score
Savino Sciascia et al.
RHEUMATOLOGY (2013)
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events
Kotaro Otomo et al.
ARTHRITIS AND RHEUMATISM (2012)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome
Francesca Crovetto et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2012)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
Association of IgA Anti-beta 2 Glycoprotein I with Clinical and Laboratory Manifestations of Systemic Lupus Erythematosus
Taraneh Mehrani et al.
JOURNAL OF RHEUMATOLOGY (2011)
The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis
J. H. Rand et al.
LUPUS (2010)
Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome
Fadi Fakhouri et al.
BLOOD (2008)
Platelet C4d Is Associated With Acute Ischemic Stroke and Stroke Severity
Nidhi Mehta et al.
STROKE (2008)
Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
S. Liestol et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Platelet C4d is highly specific for systemic lupus erythematosus
JS Navratil et al.
ARTHRITIS AND RHEUMATISM (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor
F Fischetti et al.
BLOOD (2005)
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia
SS Pierangeli et al.
ARTHRITIS AND RHEUMATISM (2005)
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice
JM Thurman et al.
MOLECULAR IMMUNOLOGY (2005)
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation
G Girardi et al.
NATURE MEDICINE (2004)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli et al.
BLOOD (2003)
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
RA Asherson et al.
LUPUS (2003)
Complement C3 activation is required for antiphospholipid antibody-induced fetal loss
VM Holers et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Share Paper
